Healthcare Insurance Market Size, Share and Future Scope

The healthcare insurance market size is projected to contribute a revenue of $2.2 trillion by 2024, witnessing a CAGR of 4.3% during the forecast period, according to P&S Intelligence. Increasing prevalence of chronic diseases, rising geriatric population, growing GDP and healthcare expenditure, and high medical costs are driving the progress of the sector. Healthcare insurance is a kind of insurance that covers surgical and medical expenses, which is directly paid to healthcare providers for the treatment of an insured individual. The policy holder can pay the premium monthly or annually on their discretion.



Based on coverage type, the healthcare insurance market is categorized into lifetime and term coverages. Out of these, in 2018, the term coverage category contributed a revenue of $1.3 trillion and is expected to be the faster-growing category, advancing at a CAGR of 4.7% in the analysis period. Term coverage is a fixed-term policy, which provides benefit upon the death of an insured individual. Due to the benefits associated with term coverage, such as low-cost premium and receipt of a lump sum amount when the term ends, the category is predicted to progress.

Now, when segmented by insurer type, minors, adults, and senior citizens are the divisions of the healthcare insurance market. Out of these, insurance plans for adults are anticipated to dominate the market across the globe. In 2018, adults generated a revenue of nearly $0.9 trillion for the market, which is projected to reach $1.2 trillion by 2024. On the other side, the minors category is expected to witness slower growth, advancing at a CAGR of 2.9% in coming years, owing to the fact that minors are dependent on adults and mostly covered in the insurance plans for grown-ups.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=healthcare-insurance-market

Currently, the world is experiencing a significant rise in the geriatric population. In 2017, according to the World Population Prospects report published by the United Nations, geriatric population is predicted to grow faster as compared to the that of other age groups. The report states that there were 962 million people aged 60 years and above in 2017, globally, and this number is estimated to reach 1.4 billion by 2030, 2.1 billion by 2050, and 3.1 billion by 2100. This is further expected to result in the growth of the healthcare insurance market, as more aged people will lead to more plans being sold.

Hence, with the increase in the geriatric population across the globe, the demand for healthcare insurance plans is expected to rise.

Infection Surveillance Solutions Market Size and Forecast Report 2024

The global infection surveillance solutions market size is growing due to the emergence of diseases caused by microorganisms that were previously not known. The microorganisms living naturally within the body are not considered as infectious for example, bacteria that normally live within the mouth and intestine such as E. coli do not cause an infection to the body. Hospital associated infections such as urinary tract infection, surgical site infections and pneumonia are increasing due to the use of contaminated devices, patient clothing, and other materials used in hospitals and clinics. This has thus provoked healthcare professionals and hospitals to adopt infection surveillance solutions to identify possible infections during the time the patient remains in hospital, and to develop necessary preventive measures for the same. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sterile medical devices.



The growth in the global infection surveillance solutions market is expected to be mainly due to the increasing incidence of HAIs; policies introduced by government for preventing these HAIs; and increase in expenditure in healthcare sector. According to World Health Organization (WHO), 9.9% of the gross domestic product (GDP) of the world was spent on healthcare in 2014. Furthermore, cost-effectiveness, and redundancy of clinical data and the increase in number of surgeries drive the growth of infection surveillance solutions market.

Download report sample at: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market/report-sample

The high cost of software of infection surveillance solutions; lack of skilled IT professionals in the healthcare industry; lack of proper healthcare infrastructure in underdeveloped and developing countries; and a low tendency of doctors to shift from traditional clinical solution practices to new alternatives, limit the growth of infection surveillance solutions market.

Geographically, North America accounts for the largest market share in the global infection surveillance solutions market, which is attributable to the increasing occurrence of HAIs, favorable government policies for preventing HAIs, and rising healthcare expenditure in this region.

Various players in the infection surveillance solutions market are focusing on collaborating with other companies to expand their product and service offerings as well as introduction of new treatment methods into the infection surveillance solutions market.

Blood Plasma Product Market Scenario, Leading Players, Segments Analysis and Forecast to 2024

The global blood plasma product market size is expected to witness a significant growth during the forecast period due to the high demand by a large pool of patients with no alternative therapeutic approach. Blood plasma product have a wide range of components that have clinical use such as, Albumin, Factor VIII, Factor IX, immunoglobulin, fibrinogen with their major applications in bleeding disorders (haemophilia, immunological disorders), massive hemorrhage and in traumatic injuries. Moreover, the presence of biomarkers in plasma adds to their application in clinical diagnosis of diseases. These factors will drive the growth of global blood plasma product market in future.



Segmentation on the basis of application includes neurology, immunology, hematology, pulmonology, hemato-oncology, rheumatology, critical care and others. Globally, the demand for plasma product was largest in hospitals and clinics due to the large patient population. Other key end users in the global blood plasma product market are clinical research laboratories, and academic institutes.

Pre-Purchase inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=blood-plasma-product-market

According to a report by World Federation of Haemophilia, there are 304,362 people suffering from bleeding disorders such as, haemophilia, von Willebrand disease and others. The statistics depict 5.6% increase in prevalence of diseases from 2014-2015. The present therapeutics involve a continuous supply of plasma product as supplement. This increase in prevalence of bleeding disorders will drive a positive impact on the growth of the market during the forecast period.

Geographically, North America held the largest share in the global blood plasma product market in 2016, followed by Europe. North America was the prominent market for the blood plasma collection, fractionation and product formation. Asia Pacific global blood plasma product market is expected to witness the fastest growth during the forecast period. The growing geriatric population and the increase in prevalence of blood disorder diseases are the factors responsible for the growth.

Pharmacovigilance Market Overview, Share and Future Scope

The global pharmacovigilance market is growing significantly due to increasing concern for drug safety, increasing incidences of adverse drug reactions and toxicity, and high patient compliance for drug usage. In addition, government and non-government organizations are actively involved in determining drug safety and efficacy, which in turn is supporting growth of global pharmacovigilance market. Massive unexplored pharmacovigilance market in emerging economies and increasing pharmaceutical companies’ compliance for outsourcing services are creating ample opportunities for the global pharmacovigilance market.

Pre-Purchase inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=pharmacovigilance-market

Pharmacovigilance is the process of monitoring and preventing adverse drug reactions. According to the WHO, pharmacovigilance can be defined as the science and activities concerned with the detection, assessment, understanding and prevention of adverse reactions to medicine. Pharmacovigilance determines drug safety and efficacy and improves patient care and public health by preventing adverse drug reactions. Adverse drug reaction is harmful, unintended, and uncomfortable effects of a drug. According to the studies conducted by WHO in developed countries, approximately 5% of hospitalized patients are admitted in the hospitals due to adverse drug reaction, and 6-10% of these patients would suffer from serious adverse drug reactions. Pharmaceutical and biotechnology companies are actively involved in the development of new drugs; this creates an increased demand for pharmacovigillance.

The major drivers in the global pharmacovigilance market are increasing incidences of adverse drug reactions and toxicity, increasing patient compliance for drug usage, and increasing concern for drug safety and efficacy. In addition, increasing involvement of government and non-government organization to determine drug safety and efficacy is propelling the growth of the global pharmacovigilance market. On the other hand, high risk of data breach through outsourcing of pharmacovigilance and shortage of skilled professionals are some of the factors restraining the growth of the global pharmacovigilance market to some extent.

Some of the major players operating in the global pharmacovigilance market are Sanofi, Cognizant Technology Solutions, Accenture, Wipro Limited, F. Hoffmann-La Roche Ltd., ICON plc, Clinquest Group B.V., Pfizer Inc., PAREXEL International Corporation, Novartis AG, iGATE Corporation, GlaxoSmithKline, and Bristol-Myers Squibb Company.

Revenue Cycle Management Market Share and Future Scope

The worldwide revenue cycle management market is witnessing considerable growth due to increasing regulatory requirements for the usage of revenue cycle management, increase in recovery audits due to changing healthcare regulations and increasing government support for revenue cycle management. Moreover, process improvements in healthcare organizations, increasing prevalence of chronic diseases and growing geriatric population are resulting in increased demand of revenue cycle management. Increasing number of patients and growth in demand for health insurance, increasing healthcare delivery cost, and decline in reimbursement rates are further supporting the market growth.

Based on product type, the market for integrated segment is estimated to increase at the faster rate during the forecast period, due to increasing demand of integrated solution to achieve process efficiency and cost reduction. Based on deployment method, the market for web-based segment leads the global market due to growing demand for mobile support system for better patient engagement solution.

Request for sample copy of this report: https://www.psmarketresearch.com/market-analysis/revenue-cycle-management-market/report-sample

The increasing demand for cloud based revenue cycle solution and vendor consolidation to provide end-to-end solution are expected to create opportunities for the players in the market. In addition, immense unexplored market in developing economies are creating abundant opportunities for the revenue cycle management market to grow at a significant rate in the coming years. However, high cost of deployment, lack of data security, limited trained IT personnel, and infrastructural loop holes in developing countries are the key factors hampering the growth of the global market.

The key players operating in the global market are Cerner Corporation, McKesson Corporation, Athenahealth Inc., Eclinicalworks LLC., Quest Diagnostics Incorporated, Allscripts Healthcare Solutions Inc., GE Healthcare, and Epic Systems Corporation.